Use of allogenic acellular dermal matrix in prevention of Frey's syndrome after parotidectomy

References 

1. Tugnoli V, Marchese Ragona R, Elropra R, et al. The role of gustatory flushing in Frey's's syndrome and its treatment with botulinum toxin type A. Clin Auton Res. 2002;12:174–178
   • MEDLINE
   • CrossRef
2. Upton DC, McNamar JP, Connor NP, Harari PM, Hartig GK. Parotidectomy: ten-year review of 237 cases at a single institution. Otolaryngol Head Neck Surg. 2007;136:788–792
   • MEDLINE
   • CrossRef
3. Dulguerov P, Quinodoz D, Cosendai G, Piletta P, Marchal F, Lehmann W. Prevention of Frey's syndrome during parotidectomy. Arch Otolaryngol Head Neck Surg. 1999;125:833–839
   • MEDLINE
4. Govindaraj S, Cohen M, Genden EM, Constantine PD, Urken ML. The use of acellular dermis in the prevention of Frey's's syndrome. Laryngoscope. 2001;111:1993–1998
   • MEDLINE
   • CrossRef
5. Hancock BD. Clinically benign parotid tumours: local dissection as an alternative to superficial parotidectomy in selected cases. Ann R Coll Surg Engl. 1999;81:299–301
   • MEDLINE
6. Papadogeorgakis N, Skouteris CA, Mylonas AI, Angelopoulos AP. Superficial parotidectomy: technical modifications based on tumour characteristics. J Craniomaxillofac Surg. 2004;32:350–353
   • Abstract
   • Full Text
   • Full-Text PDF (92 KB)
7. Ahmed OA, Kolhe PS. Prevention of Frey's's syndrome and volume deficit after parotidectomy using the superficial temporal artery fascial flap. Br J Plast Surg. 1999;52:256–260
   • Abstract
   • Full-Text PDF (280 KB)
   • CrossRef
8. Rubinstein RY, Rosen A, Leeman D. Frey's syndrome: treatment with temporoparietal fascia flap interposition. Arch Otolaryngol Head Neck Surg. 1999;125:808–811
   • MEDLINE
9. Arad-Cohen A, Blitzer A. Botulinum toxin treatment for symptomatic Frey's's syndrome. Otolaryngol Head Neck Surg. 2000;122:237–240
   • MEDLINE
   • CrossRef
10. Laccourreye O, Akl E, Gutierrez-Fonseca R, Garcia D, Brasnu D, Bonan B. Recurrent gustatory sweating (Frey's syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome. Arch Otolaryngol Head Neck Surg. 1999;125:283–286
    • MEDLINE
11. May JS, McGuirt WF. Frey's's syndrome: treatment with topical glycopyrrolate. Head Neck. 1989;111:85–89